Stereotaxis Inc (STXS)
2.085
-0.12
(-5.23%)
USD |
NYAM |
Nov 14, 16:00
2.085
0.00 (0.00%)
After-Hours: 20:00
Stereotaxis Research and Development Expense (Quarterly): 2.273M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.273M |
| March 31, 2024 | 2.243M |
| December 31, 2023 | 2.212M |
| September 30, 2023 | 2.668M |
| June 30, 2023 | 2.647M |
| March 31, 2023 | 2.746M |
| December 31, 2022 | 2.40M |
| September 30, 2022 | 2.818M |
| June 30, 2022 | 2.893M |
| March 31, 2022 | 2.447M |
| December 31, 2021 | 2.615M |
| September 30, 2021 | 2.50M |
| June 30, 2021 | 2.717M |
| March 31, 2021 | 2.367M |
| December 31, 2020 | 2.098M |
| September 30, 2020 | 1.953M |
| June 30, 2020 | 1.977M |
| March 31, 2020 | 2.109M |
| December 31, 2019 | 1.616M |
| September 30, 2019 | 1.751M |
| June 30, 2019 | 2.695M |
| March 31, 2019 | 2.959M |
| December 31, 2018 | 2.224M |
| September 30, 2018 | 2.001M |
| June 30, 2018 | 2.032M |
| Date | Value |
|---|---|
| March 31, 2018 | 1.963M |
| December 31, 2017 | 1.727M |
| September 30, 2017 | 1.620M |
| June 30, 2017 | 1.756M |
| March 31, 2017 | 1.601M |
| December 31, 2016 | 1.298M |
| September 30, 2016 | 1.295M |
| June 30, 2016 | 1.421M |
| March 31, 2016 | 1.473M |
| December 31, 2015 | 1.853M |
| September 30, 2015 | 1.494M |
| June 30, 2015 | 1.420M |
| March 31, 2015 | 1.486M |
| December 31, 2014 | 1.128M |
| September 30, 2014 | 1.214M |
| June 30, 2014 | 1.313M |
| March 31, 2014 | 1.503M |
| December 31, 2013 | 1.358M |
| September 30, 2013 | 1.300M |
| June 30, 2013 | 1.484M |
| March 31, 2013 | 1.529M |
| December 31, 2012 | 1.479M |
| September 30, 2012 | 1.905M |
| June 30, 2012 | 2.196M |
| March 31, 2012 | 2.825M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.616M
Minimum
Dec 2019
2.893M
Maximum
Jun 2022
2.384M
Average
2.40M
Median
Dec 2022
Research and Development Expense (Quarterly) Benchmarks
| Cutera Inc | 4.353M |
| IRIDEX Corp | 1.501M |
| Electromed Inc | 0.176M |
| Axogen Inc | 6.996M |
| Myomo Inc | 1.249M |